Predictive biomarkers in colorectal adenocarcinoma - a Brazilian perspective on current and future practices

Abstract Predictive biomarkers of response to therapy are fundamental for the personalized therapeutic management of patients with colorectal carcinoma (CRC). The main predictive biomarkers related to CRC are the mismatch repair proteins/microsatellite instability status (MMR/MSI status), RAS/RAF mu...

Full description

Saved in:
Bibliographic Details
Main Authors: Antonio Hugo José Fróes Marques Campos (Author), Luciana Campi Auresco (Author), Lidiane Vieira Marins (Author), Paulo Henrique do Amor Divino (Author), Jorge Sabbaga (Author), Paulo Marcelo Hoff (Author)
Format: Book
Published: BMC, 2024-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Predictive biomarkers of response to therapy are fundamental for the personalized therapeutic management of patients with colorectal carcinoma (CRC). The main predictive biomarkers related to CRC are the mismatch repair proteins/microsatellite instability status (MMR/MSI status), RAS/RAF mutation status and HER2 status. We discuss the scenarios in which these biomarkers are used and address different aspects that may affect the evaluation of each biomarker. We also address the increasingly recognized importance of circulating tumor DNA (ctDNA) testing in the management of stage II-III CRC as well as the role of the pathologist in this setting.
Item Description:10.1186/s42047-024-00163-3
2520-8454